Follow the people · Insider
Benjamin J. Hindson
Benjamin J. Hindson files insider transactions with the SEC as a director and officer of 10x Genomics (TXG). We hold 3 disclosed purchases and sales filed since 16 September 2019, 1 of them in the last 90 days.
- Files forTXG
- Disclosed buys and sells3 in all, 1 in the last 90 days
- Last disclosure26 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 16 September 2019 — 24 August 2026Director and Officer · 10x Genomics (TXG)282 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 13,818 shares of 10x GenomicsSEC Form 426 August 2026Class A Common Stock · traded 24 August 2026 · filed 26 August 2026
- ▼ sold on the open market 11,595 shares of 10x GenomicsSEC Form 427 May 2026Class A Common Stock · traded 22 May 2026 · filed 27 May 2026
- was granted 88,816 shares of 10x GenomicsSEC Form 42 March 2026Class A Common Stock · traded 26 February 2026 · filed 2 March 2026
- was granted 88,816 shares of 10x GenomicsSEC Form 42 March 2026Class A Common Stock · traded 26 February 2026 · filed 2 March 2026
- ▼ sold on the open market 7,826 shares of 10x GenomicsSEC Form 425 February 2026Class A Common Stock · traded 23 February 2026 · filed 25 February 2026
- ▼ sold on the open market 7,826 shares of 10x GenomicsSEC Form 425 February 2026Class A Common Stock · traded 23 February 2026 · filed 25 February 2026
- ▼ sold on the open market 8,283 shares of 10x GenomicsSEC Form 425 November 2025Class A Common Stock · traded 24 November 2025 · filed 25 November 2025
- ▼ sold on the open market 7,486 shares of 10x GenomicsSEC Form 426 August 2025Class A Common Stock · traded 22 August 2025 · filed 26 August 2025
- ▼ sold on the open market 7,485 shares of 10x GenomicsSEC Form 427 May 2025Class A Common Stock · traded 22 May 2025 · filed 27 May 2025
- was granted 120,535 shares of 10x GenomicsSEC Form 419 March 2025Class A Common Stock · traded 17 March 2025 · filed 19 March 2025
- ▼ sold on the open market 4,573 shares of 10x GenomicsSEC Form 426 February 2025Class A Common Stock · traded 24 February 2025 · filed 26 February 2025
- ▼ sold on the open market 5,807 shares of 10x GenomicsSEC Form 425 November 2024Class A Common Stock · traded 22 November 2024 · filed 25 November 2024
- ▼ sold on the open market 4,351 shares of 10x GenomicsSEC Form 426 August 2024Class A Common Stock · traded 22 August 2024 · filed 26 August 2024
- ▼ sold on the open market 4,087 shares of 10x GenomicsSEC Form 423 May 2024Class A Common Stock · traded 22 May 2024 · filed 23 May 2024
- was granted 71,083 shares of 10x GenomicsSEC Form 425 March 2024Class A Common Stock · traded 21 March 2024 · filed 25 March 2024
- ▼ sold on the open market 2,613 shares of 10x GenomicsSEC Form 426 February 2024Class A Common Stock · traded 22 February 2024 · filed 26 February 2024
- exercised options over 8,334 shares of 10x Genomics (a derivative holding)SEC Form 429 December 2023Stock Option (right to buy) · traded 28 December 2023 · filed 29 December 2023
- exercised options over 8,334 shares of 10x GenomicsSEC Form 429 December 2023Class A Common Stock · traded 28 December 2023 · filed 29 December 2023
- ▼ sold on the open market 3,449 shares of 10x GenomicsSEC Form 427 November 2023Class A Common Stock · traded 22 November 2023 · filed 27 November 2023
- ▼ sold on the open market 3,449 shares of 10x GenomicsSEC Form 424 August 2023Class A Common Stock · traded 22 August 2023 · filed 24 August 2023
- exercised options over 6,970 shares of 10x Genomics (a derivative holding)SEC Form 43 August 2023Stock Option (right to buy) · traded 1 August 2023 · filed 3 August 2023
- exercised options over 6,970 shares of 10x GenomicsSEC Form 43 August 2023Class A Common Stock · traded 1 August 2023 · filed 3 August 2023
- ▼ sold on the open market 1,727 shares of 10x GenomicsSEC Form 43 August 2023Class A Common Stock · traded 1 August 2023 · filed 3 August 2023
- ▼ sold on the open market 5,243 shares of 10x GenomicsSEC Form 43 August 2023Class A Common Stock · traded 1 August 2023 · filed 3 August 2023
- exercised options over 12,972 shares of 10x Genomics (a derivative holding)SEC Form 421 July 2023Stock Option (right to buy) · traded 19 July 2023 · filed 21 July 2023
- exercised options over 968 shares of 10x Genomics (a derivative holding)SEC Form 421 July 2023Stock Option (right to buy) · traded 19 July 2023 · filed 21 July 2023
- exercised options over 12,972 shares of 10x GenomicsSEC Form 421 July 2023Class A Common Stock · traded 19 July 2023 · filed 21 July 2023
- exercised options over 968 shares of 10x GenomicsSEC Form 421 July 2023Class A Common Stock · traded 19 July 2023 · filed 21 July 2023
- ▼ sold on the open market 13,940 shares of 10x GenomicsSEC Form 421 July 2023Class A Common Stock · traded 19 July 2023 · filed 21 July 2023
- ▼ sold on the open market 243 shares of 10x GenomicsSEC Form 425 May 2023Class A Common Stock · traded 23 May 2023 · filed 25 May 2023
- ▼ sold on the open market 619 shares of 10x GenomicsSEC Form 425 May 2023Class A Common Stock · traded 23 May 2023 · filed 25 May 2023
- ▼ sold on the open market 735 shares of 10x GenomicsSEC Form 425 May 2023Class A Common Stock · traded 23 May 2023 · filed 25 May 2023
- ▼ sold on the open market 791 shares of 10x GenomicsSEC Form 425 May 2023Class A Common Stock · traded 23 May 2023 · filed 25 May 2023
- was granted 36,387 shares of 10x Genomics (a derivative holding)SEC Form 423 March 2023Stock Option (right to buy) · traded 21 March 2023 · filed 23 March 2023
- was granted 18,194 shares of 10x Genomics (a derivative holding)SEC Form 423 March 2023Performance- based Restricted Stock Units · traded 21 March 2023 · filed 23 March 2023
- was granted 36,387 shares of 10x GenomicsSEC Form 423 March 2023Class A Common Stock · traded 21 March 2023 · filed 23 March 2023
- ▼ sold on the open market 1,742 shares of 10x GenomicsSEC Form 424 February 2023Class A Common Stock · traded 22 February 2023 · filed 24 February 2023
- exercised options over 34,266 shares of 10x Genomics (a derivative holding)SEC Form 416 December 2022Stock Option (right to buy) · traded 14 December 2022 · filed 16 December 2022
- exercised options over 34,266 shares of 10x GenomicsSEC Form 416 December 2022Class A Common Stock · traded 14 December 2022 · filed 16 December 2022
- ▼ sold on the open market 359 shares of 10x GenomicsSEC Form 423 November 2022Class A Common Stock · traded 22 November 2022 · filed 23 November 2022
- ▼ sold on the open market 915 shares of 10x GenomicsSEC Form 423 November 2022Class A Common Stock · traded 22 November 2022 · filed 23 November 2022
- ▼ sold on the open market 1,087 shares of 10x GenomicsSEC Form 423 November 2022Class A Common Stock · traded 22 November 2022 · filed 23 November 2022
- was granted 67,655 shares of 10x Genomics (a derivative holding)SEC Form 416 September 2022Stock Option (right to buy) · traded 14 September 2022 · filed 16 September 2022
- was granted 67,655 shares of 10x Genomics (a derivative holding)SEC Form 416 September 2022Performance-based Restricted Stock Units · traded 14 September 2022 · filed 16 September 2022
- was granted 33,828 shares of 10x GenomicsSEC Form 416 September 2022Class A Common Stock · traded 14 September 2022 · filed 16 September 2022
- ▼ sold on the open market 1,292 shares of 10x GenomicsSEC Form 425 August 2022Class A Common Stock · traded 23 August 2022 · filed 25 August 2022
- ▼ sold on the open market 1,264 shares of 10x GenomicsSEC Form 425 May 2022Class A Common Stock · traded 23 May 2022 · filed 25 May 2022
- was granted 71,189 shares of 10x Genomics (a derivative holding)SEC Form 424 March 2022Stock Option (Right to Buy) · traded 22 March 2022 · filed 24 March 2022
- was granted 28,476 shares of 10x GenomicsSEC Form 424 March 2022Class A Common Stock · traded 22 March 2022 · filed 24 March 2022
- gave away 267,000 shares of 10x Genomics (a derivative holding)SEC Form 424 February 2022Class B Common Stock · traded 22 February 2022 · filed 24 February 2022
- gave away 133,500 shares of 10x Genomics (a derivative holding)SEC Form 424 February 2022Class B Common Stock · traded 22 February 2022 · filed 24 February 2022
- gave away 133,500 shares of 10x Genomics (a derivative holding)SEC Form 424 February 2022Class B Common Stock · traded 22 February 2022 · filed 24 February 2022
- ▼ sold on the open market 360 shares of 10x GenomicsSEC Form 424 February 2022Class A Common Stock · traded 22 February 2022 · filed 24 February 2022
- exercised options over 2,084 shares of 10x Genomics (a derivative holding)SEC Form 45 January 2022Stock Option (right to buy) · traded 3 January 2022 · filed 5 January 2022
- exercised options over 39,582 shares of 10x Genomics (a derivative holding)SEC Form 45 January 2022Stock Option (right to buy) · traded 3 January 2022 · filed 5 January 2022
- exercised options over 2,084 shares of 10x GenomicsSEC Form 45 January 2022Class A Common Stock · traded 3 January 2022 · filed 5 January 2022
- exercised options over 39,582 shares of 10x GenomicsSEC Form 45 January 2022Class A Common Stock · traded 3 January 2022 · filed 5 January 2022
- ▼ sold on the open market 2,300 shares of 10x GenomicsSEC Form 45 January 2022Class A Common Stock · traded 3 January 2022 · filed 5 January 2022
- ▼ sold on the open market 16,464 shares of 10x GenomicsSEC Form 45 January 2022Class A Common Stock · traded 3 January 2022 · filed 5 January 2022
- ▼ sold on the open market 17,396 shares of 10x GenomicsSEC Form 45 January 2022Class A Common Stock · traded 3 January 2022 · filed 5 January 2022
- ▼ sold on the open market 2,906 shares of 10x GenomicsSEC Form 45 January 2022Class A Common Stock · traded 3 January 2022 · filed 5 January 2022
- ▼ sold on the open market 2,000 shares of 10x GenomicsSEC Form 45 January 2022Class A Common Stock · traded 3 January 2022 · filed 5 January 2022
- ▼ sold on the open market 600 shares of 10x GenomicsSEC Form 45 January 2022Class A Common Stock · traded 3 January 2022 · filed 5 January 2022
- exercised options over 53,952 shares of 10x Genomics (a derivative holding)SEC Form 430 December 2021Stock Option (right to buy) · traded 28 December 2021 · filed 30 December 2021
- exercised options over 59,968 shares of 10x Genomics (a derivative holding)SEC Form 430 December 2021Stock Option (right to buy) · traded 28 December 2021 · filed 30 December 2021
- exercised options over 53,952 shares of 10x GenomicsSEC Form 430 December 2021Class A Common Stock · traded 28 December 2021 · filed 30 December 2021
- exercised options over 59,968 shares of 10x GenomicsSEC Form 430 December 2021Class A Common Stock · traded 28 December 2021 · filed 30 December 2021
- exercised options over 3,646 shares of 10x Genomics (a derivative holding)SEC Form 43 December 2021Stock Option (right to buy) · traded 1 December 2021 · filed 3 December 2021
- exercised options over 35,232 shares of 10x Genomics (a derivative holding)SEC Form 43 December 2021Stock Option (right to buy) · traded 1 December 2021 · filed 3 December 2021
- exercised options over 2,788 shares of 10x Genomics (a derivative holding)SEC Form 43 December 2021Stock Option (right to buy) · traded 1 December 2021 · filed 3 December 2021
- exercised options over 3,646 shares of 10x GenomicsSEC Form 43 December 2021Class A Common Stock · traded 1 December 2021 · filed 3 December 2021
- exercised options over 35,232 shares of 10x GenomicsSEC Form 43 December 2021Class A Common Stock · traded 1 December 2021 · filed 3 December 2021
- exercised options over 2,788 shares of 10x GenomicsSEC Form 43 December 2021Class A Common Stock · traded 1 December 2021 · filed 3 December 2021
- ▼ sold on the open market 5,400 shares of 10x GenomicsSEC Form 43 December 2021Class A Common Stock · traded 1 December 2021 · filed 3 December 2021
- ▼ sold on the open market 5,369 shares of 10x GenomicsSEC Form 43 December 2021Class A Common Stock · traded 1 December 2021 · filed 3 December 2021
- ▼ sold on the open market 13,561 shares of 10x GenomicsSEC Form 43 December 2021Class A Common Stock · traded 1 December 2021 · filed 3 December 2021
- ▼ sold on the open market 7,571 shares of 10x GenomicsSEC Form 43 December 2021Class A Common Stock · traded 1 December 2021 · filed 3 December 2021
- ▼ sold on the open market 4,849 shares of 10x GenomicsSEC Form 43 December 2021Class A Common Stock · traded 1 December 2021 · filed 3 December 2021
- ▼ sold on the open market 1,816 shares of 10x GenomicsSEC Form 43 December 2021Class A Common Stock · traded 1 December 2021 · filed 3 December 2021
- ▼ sold on the open market 2,100 shares of 10x GenomicsSEC Form 43 December 2021Class A Common Stock · traded 1 December 2021 · filed 3 December 2021
- ▼ sold on the open market 100 shares of 10x GenomicsSEC Form 43 December 2021Class A Common Stock · traded 1 December 2021 · filed 3 December 2021
- ▼ sold on the open market 700 shares of 10x GenomicsSEC Form 43 December 2021Class A Common Stock · traded 1 December 2021 · filed 3 December 2021
- ▼ sold on the open market 200 shares of 10x GenomicsSEC Form 43 December 2021Class A Common Stock · traded 1 December 2021 · filed 3 December 2021
- ▼ sold on the open market 351 shares of 10x GenomicsSEC Form 424 November 2021Class A Common Stock · traded 22 November 2021 · filed 24 November 2021
- exercised options over 10,232 shares of 10x Genomics (a derivative holding)SEC Form 43 November 2021Stock Option (right to buy) · traded 1 November 2021 · filed 3 November 2021
- exercised options over 31,434 shares of 10x Genomics (a derivative holding)SEC Form 43 November 2021Stock Option (right to buy) · traded 1 November 2021 · filed 3 November 2021
- exercised options over 10,232 shares of 10x GenomicsSEC Form 43 November 2021Class A Common Stock · traded 1 November 2021 · filed 3 November 2021
- exercised options over 31,434 shares of 10x GenomicsSEC Form 43 November 2021Class A Common Stock · traded 1 November 2021 · filed 3 November 2021
- ▼ sold on the open market 1,100 shares of 10x GenomicsSEC Form 43 November 2021Class A Common Stock · traded 1 November 2021 · filed 3 November 2021
- ▼ sold on the open market 1,500 shares of 10x GenomicsSEC Form 43 November 2021Class A Common Stock · traded 1 November 2021 · filed 3 November 2021
- ▼ sold on the open market 11,829 shares of 10x GenomicsSEC Form 43 November 2021Class A Common Stock · traded 1 November 2021 · filed 3 November 2021
- ▼ sold on the open market 24,125 shares of 10x GenomicsSEC Form 43 November 2021Class A Common Stock · traded 1 November 2021 · filed 3 November 2021
- ▼ sold on the open market 3,112 shares of 10x GenomicsSEC Form 43 November 2021Class A Common Stock · traded 1 November 2021 · filed 3 November 2021
- exercised options over 41,666 shares of 10x Genomics (a derivative holding)SEC Form 45 October 2021Stock Option (right to buy) · traded 1 October 2021 · filed 5 October 2021
- exercised options over 41,666 shares of 10x GenomicsSEC Form 45 October 2021Class A Common Stock · traded 1 October 2021 · filed 5 October 2021
- ▼ sold on the open market 4,400 shares of 10x GenomicsSEC Form 45 October 2021Class A Common Stock · traded 1 October 2021 · filed 5 October 2021
- ▼ sold on the open market 13,297 shares of 10x GenomicsSEC Form 45 October 2021Class A Common Stock · traded 1 October 2021 · filed 5 October 2021
- ▼ sold on the open market 21,469 shares of 10x GenomicsSEC Form 45 October 2021Class A Common Stock · traded 1 October 2021 · filed 5 October 2021
- ▼ sold on the open market 2,500 shares of 10x GenomicsSEC Form 45 October 2021Class A Common Stock · traded 1 October 2021 · filed 5 October 2021
- exercised options over 41,666 shares of 10x Genomics (a derivative holding)SEC Form 43 September 2021Stock Option (right to buy) · traded 1 September 2021 · filed 3 September 2021
- exercised options over 41,666 shares of 10x GenomicsSEC Form 43 September 2021Class A Common Stock · traded 1 September 2021 · filed 3 September 2021
- ▼ sold on the open market 1,049 shares of 10x GenomicsSEC Form 43 September 2021Class A Common Stock · traded 1 September 2021 · filed 3 September 2021
- ▼ sold on the open market 2,728 shares of 10x GenomicsSEC Form 43 September 2021Class A Common Stock · traded 1 September 2021 · filed 3 September 2021
- ▼ sold on the open market 7,530 shares of 10x GenomicsSEC Form 43 September 2021Class A Common Stock · traded 1 September 2021 · filed 3 September 2021
- ▼ sold on the open market 21,145 shares of 10x GenomicsSEC Form 43 September 2021Class A Common Stock · traded 1 September 2021 · filed 3 September 2021
- ▼ sold on the open market 8,586 shares of 10x GenomicsSEC Form 43 September 2021Class A Common Stock · traded 1 September 2021 · filed 3 September 2021
- ▼ sold on the open market 628 shares of 10x GenomicsSEC Form 43 September 2021Class A Common Stock · traded 1 September 2021 · filed 3 September 2021
- ▼ sold on the open market 337 shares of 10x GenomicsSEC Form 425 August 2021Class A Common Stock · traded 23 August 2021 · filed 25 August 2021
- exercised options over 11,114 shares of 10x Genomics (a derivative holding)SEC Form 44 August 2021Stock Option (right to buy) · traded 2 August 2021 · filed 4 August 2021
- exercised options over 30,552 shares of 10x Genomics (a derivative holding)SEC Form 44 August 2021Stock Option (right to buy) · traded 2 August 2021 · filed 4 August 2021
- exercised options over 11,114 shares of 10x GenomicsSEC Form 44 August 2021Class A Common Stock · traded 2 August 2021 · filed 4 August 2021
- exercised options over 30,552 shares of 10x GenomicsSEC Form 44 August 2021Class A Common Stock · traded 2 August 2021 · filed 4 August 2021
- ▼ sold on the open market 5,903 shares of 10x GenomicsSEC Form 44 August 2021Class A Common Stock · traded 2 August 2021 · filed 4 August 2021
- ▼ sold on the open market 8,050 shares of 10x GenomicsSEC Form 44 August 2021Class A Common Stock · traded 2 August 2021 · filed 4 August 2021
- ▼ sold on the open market 10,713 shares of 10x GenomicsSEC Form 44 August 2021Class A Common Stock · traded 2 August 2021 · filed 4 August 2021
- ▼ sold on the open market 8,800 shares of 10x GenomicsSEC Form 44 August 2021Class A Common Stock · traded 2 August 2021 · filed 4 August 2021
- ▼ sold on the open market 5,200 shares of 10x GenomicsSEC Form 44 August 2021Class A Common Stock · traded 2 August 2021 · filed 4 August 2021
- ▼ sold on the open market 1,800 shares of 10x GenomicsSEC Form 44 August 2021Class A Common Stock · traded 2 August 2021 · filed 4 August 2021
- ▼ sold on the open market 800 shares of 10x GenomicsSEC Form 44 August 2021Class A Common Stock · traded 2 August 2021 · filed 4 August 2021
- ▼ sold on the open market 400 shares of 10x GenomicsSEC Form 44 August 2021Class A Common Stock · traded 2 August 2021 · filed 4 August 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.